查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1527091

2024 年聚乙二醇化蛋白全球市场报告

PEGylated Proteins Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年聚乙二醇化蛋白质市场规模将快速成长。 2028年，将以13.8%的复合年增长率成长至24.7亿美元。预测期内的预期成长因素包括对罕见疾病的投资增加、生物製药行业的快速扩张、精准医疗方法的采用、生技药品生物相似药版本的竞争加剧以及创新，其中包括实施打入市场策略。预测期内预计的主要趋势包括数位医疗技术的整合、下一代聚乙二醇化技术的进步、精准医疗定製配方的开发、专注于联合治疗以及向以患者为中心的医疗模式的转变。

文明病的日益流行预计将在短期内推动聚乙二醇化蛋白质市场的扩张。与文明病主要源于不健康的习惯和生活方式选择，如不良饮食习惯、久坐生活、吸烟，以及体力活动减少、加工食品消费和压力水平增加等其他因素的重迭，并且呈上升趋势。聚乙二醇化蛋白透过提高心血管疾病、糖尿病和某些癌症等疾病的治疗效果、持续时间和针对性，在文明病的治疗中发挥重要作用。例如，根据 2022 年 10 月报告，世界心臟联合会 (WHF) 预测，心血管疾病死亡人数将从 2020 年的约 1890 万人增加到 2030 年的超过 2220 万人。此外，国际糖尿病联盟 (IDF) 于 2021 年 12 月透露，全球有 5.37 亿 20 岁至 79 岁的成年人被诊断出患有糖尿病，相当于全球十分之一的人。因此，与文明病盛行率的上升正在推动聚乙二醇化蛋白质市场的成长。

聚乙二醇化蛋白质市场的主要参与企业正在专注于开拓聚乙二醇化试剂等创新产品，以保持竞争力。聚乙二醇化试剂是将聚乙二醇 (PEG) 链附着到生物分子上并改变其特性以用于各种生物医学应用的化合物。例如，美国食品添加剂和酵素供应商Creative Enzymes于2023年5月推出了用于靶向药物递送的DSPE-PEG-马来酰亚胺。 DSPE-PEG-Maleimide 是一种含有 DSPE 磷脂和马来酰亚胺的锁状异双功能聚乙二醇化试剂，可作为製备聚乙二醇化脂质体和胶束以及靶向药物靶标的有价值的自组装试剂。

目录

第一章执行概述

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球聚乙二醇化蛋白市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球聚乙二醇化蛋白市场表现：规模与成长，2018-2023
  • 全球聚乙二醇化蛋白市场预测：规模与成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球聚乙二醇化蛋白市场：按产品、性能和预测，2018-2023、2023-2028、2033
  • 消耗品和服务
  • 聚乙二醇化试剂套件和试剂
  • 单官能线性 PEG
  • 双功能聚乙二醇
  • 服务
  • 其他的
  • 全球聚乙二醇化蛋白质市场：依蛋白质类型分類的表现与预测，2018-2023、2023-2028、2033
  • 集落刺激因子
  • 干扰素
  • 促红血球生成素
  • 重组因子VII
  • 其他的
  • 全球聚乙二醇化蛋白市场：按应用、性能和预测，2018-2023、2023-2028、2033
  • 癌症治疗
  • 肝炎
  • 慢性肾臟病
  • 血友病
  • 多发性硬化症
  • 胃肠道疾病
  • 其他的
  • 全球聚乙二醇化蛋白市场：按最终用户、性能和预测，2018-2023、2023-2028、2033
  • 药品
  • 生技公司
  • 受託研究机构
  • 学术研究所

第 7 章 区域/国家分析

  • 全球聚乙二醇化蛋白市场：按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球聚乙二醇化蛋白市场：依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 聚乙二醇化蛋白质市场：竞争格局
  • 聚乙二醇化蛋白质市场：公司简介
    • Merck & Co. Inc.
    • Bayer AG
    • Bristol Myers Squibb Company
    • AstraZeneca PLC
    • Roche Holding AG

第31章 其他大型创新企业

  • Gilead Sciences Inc.
  • Novo Nordisk A/S
  • Evonik Industries AG
  • Viatris Inc.
  • Regeneron Pharmaceuticals Inc.
  • Biogen Inc.
  • Vertex Pharmaceuticals Incorporated
  • Lonza Group Ltd.
  • Jazz Pharmaceuticals plc
  • Ipsen Pharma
  • Kyowa Kirin Co. Ltd.
  • WuXi Biologics
  • BioMarin Pharmaceutical Inc.
  • Ligand Pharmaceuticals Incorporated
  • Zydus Cadila

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r18696

PEGylated proteins are therapeutic proteins covalently bonded to polyethylene glycol (PEG), a process aimed at enhancing their pharmacokinetic properties and reducing immunogenicity, thus improving their therapeutic efficacy. These modified proteins find application in various medical fields, including drug delivery, diagnostics, and targeted therapy, offering prolonged action and potentially improving patient outcomes.

The primary products within the PEGylated proteins market include consumables and services, pegylation kits and reagents, monofunctional linear PEGs, bifunctional PEGs, and others. Consumables and services constitute a broad category encompassing products and services vital for PEGylated protein research and development, including kits, reagents, and various support services. The proteins themselves cover a range of types such as colony-stimulating factors, interferons, erythropoietin, recombinant factor VII, and others, serving diverse applications including cancer treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis, gastrointestinal disorders, and more. End users of these products and services include pharmaceutical companies, biotechnology firms, contract research organizations, and academic research institutes.

The PEGylated proteins market research report is one of a series of new reports from The Business Research Company that provides PEGylated proteins market statistics, including the PEGylated proteins industry global market size, regional shares, competitors with the PEGylated proteins market share, detailed PEGylated proteins market segments, market trends, and opportunities, and any further data you may need to thrive in the PEGylated proteins industry. These PEGylated proteins market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The PEGylated proteins market size has grown rapidly in recent years. It will grow from $1.29 billion in 2023 to $1.47 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth observed during the historic period can be attributed to several factors, including enhanced therapeutic efficacy, a growing aging population, increased demand for long-acting formulations, improved drug safety profiles, and expanding applications, particularly in targeted drug delivery systems.

The PEGylated proteins market size is expected to see rapid growth in the next few years. It will grow to $2.47 billion in 2028 at a compound annual growth rate (CAGR) of 13.8%. The anticipated growth in the forecast period can be attributed to several factors, including increasing investment in rare diseases, the rapid expansion of the biopharmaceutical industry, the adoption of precision medicine approaches, heightened competition from biosimilar versions of biologic drugs, and the implementation of innovative market access strategies. Major trends expected in the forecast period include the integration of digital health technologies, the advancement of next-generation pegylation technologies, the development of customized formulations for precision medicine, a focus on combination therapies, and a shift towards patient-centric healthcare models.

The increasing prevalence of lifestyle diseases is set to drive the expansion of the PEGylated proteins market in the foreseeable future. Lifestyle diseases, which arise primarily from unhealthy habits and lifestyle choices such as poor diet, sedentary behavior, and smoking, are on the rise due to a combination of factors including reduced physical activity, consumption of processed foods, and heightened stress levels. PEGylated proteins play a crucial role in treating lifestyle diseases by improving the effectiveness, duration, and targeted delivery of therapeutic agents for conditions such as cardiovascular diseases, diabetes, and certain cancers. For example, the World Heart Federation (WHF) projected an increase in cardiovascular disease deaths from approximately 18.9 million in 2020 to over 22.2 million in 2030, as reported in October 2022. Additionally, the International Diabetes Federation (IDF) revealed in December 2021 that 537 million adults aged 20 to 79 years worldwide were diagnosed with diabetes, representing 1 in 10 individuals. Hence, the rising prevalence of lifestyle diseases is fueling the growth of the PEGylated proteins market.

Key players in the PEGylated proteins market are focusing on the development of innovative products such as PEGylation reagents to maintain a competitive edge. PEGylation reagents are chemical compounds that attach polyethylene glycol (PEG) chains to biomolecules, modifying their properties for various biomedical applications. For instance, Creative Enzymes, a US-based supplier of food additives and enzymes, introduced DSPE-PEG-Maleimide in May 2023 for targeted drug delivery. DSPE-PEG-Maleimide is a linear heterobifunctional PEGylation reagent containing DSPE phospholipids and maleimide, serving as a valuable self-assembly reagent for preparing PEGylated liposomes or micelles and providing thiol or cysteine reactive maleimide groups, commonly used in targeted drug delivery.

In February 2022, Merck KGaA, a pharmaceutical company based in Germany, acquired Exelead Inc. for $793 million to bolster its presence in the growing market for mRNA therapeutics. Exelead Inc., a US-based biopharmaceutical company specializing in GMP-certified PEGylation services for use in manufacturing process development, is expected to enhance Merck KGaA's capabilities in this sector.

Major companies operating in the PEGylated proteins market are Merck & Co. Inc., Bayer AG, Bristol Myers Squibb Company, AstraZeneca PLC, Roche Holding AG, Gilead Sciences Inc., Novo Nordisk A/S, Evonik Industries AG, Viatris Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Lonza Group Ltd., Jazz Pharmaceuticals plc, Ipsen Pharma, Kyowa Kirin Co. Ltd., WuXi Biologics, BioMarin Pharmaceutical Inc., Ligand Pharmaceuticals Incorporated, Zydus Cadila, Enzon Pharmaceuticals Inc.

North America was the largest region in the PEGylated Proteins market in 2023. The regions covered in the PEGylated proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the PEGylated proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The PEGylated proteins market consists of revenues earned by entities by providing services such as analytical services and contract manufacturing services for PEGylated protein. The market value includes the value of related goods sold by the service provider or included within the service offering. The PEGylated proteins market also includes sales of PEGylated enzymes, PEGylated antibodies, and PEGylated hormones. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

PEGylated Proteins Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pegylated proteins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pegylated proteins ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pegylated proteins market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Consumable And Services; PEGylation Kits And Reagents; Monofunctional Linear PEGs; Bifunctional PEGs; Services; Other Products
  • 2) By Protein Type: Colony Stimulating Factors; Interferons; Erythropoietin; Recombinant Factor VII; Other Protein Types
  • 3) By Application: Cancer Treatment; Hepatitis; Chronic Kidney Diseases; Hemophilia; Multiple Sclerosis; Gastrointestinal Disorders; Other Applications
  • 4) By End User: Pharmaceuticals; Biotechnology Companies; Contract Research Organizations; Academic Research Institutes
  • Companies Mentioned: Merck & Co. Inc.; Bayer AG; Bristol Myers Squibb Company; AstraZeneca PLC; Roche Holding AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. PEGylated Proteins Market Characteristics

3. PEGylated Proteins Market Trends And Strategies

4. PEGylated Proteins Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global PEGylated Proteins Market Size and Growth

  • 5.1. Global PEGylated Proteins Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global PEGylated Proteins Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global PEGylated Proteins Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. PEGylated Proteins Market Segmentation

  • 6.1. Global PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumable And Services
  • PEGylation Kits And Reagents
  • Monofunctional Linear PEGs
  • Bifunctional PEGs
  • Services
  • Other Products
  • 6.2. Global PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Colony Stimulating Factors
  • Interferons
  • Erythropoietin
  • Recombinant Factor VII
  • Other Protein Types
  • 6.3. Global PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer Treatment
  • Hepatitis
  • Chronic Kidney Diseases
  • Hemophilia
  • Multiple Sclerosis
  • Gastrointestinal Disorders
  • Other Applications
  • 6.4. Global PEGylated Proteins Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceuticals
  • Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes

7. PEGylated Proteins Market Regional And Country Analysis

  • 7.1. Global PEGylated Proteins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global PEGylated Proteins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific PEGylated Proteins Market

  • 8.1. Asia-Pacific PEGylated Proteins Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China PEGylated Proteins Market

  • 9.1. China PEGylated Proteins Market Overview
  • 9.2. China PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India PEGylated Proteins Market

  • 10.1. India PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan PEGylated Proteins Market

  • 11.1. Japan PEGylated Proteins Market Overview
  • 11.2. Japan PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia PEGylated Proteins Market

  • 12.1. Australia PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia PEGylated Proteins Market

  • 13.1. Indonesia PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea PEGylated Proteins Market

  • 14.1. South Korea PEGylated Proteins Market Overview
  • 14.2. South Korea PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe PEGylated Proteins Market

  • 15.1. Western Europe PEGylated Proteins Market Overview
  • 15.2. Western Europe PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK PEGylated Proteins Market

  • 16.1. UK PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany PEGylated Proteins Market

  • 17.1. Germany PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France PEGylated Proteins Market

  • 18.1. France PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy PEGylated Proteins Market

  • 19.1. Italy PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain PEGylated Proteins Market

  • 20.1. Spain PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe PEGylated Proteins Market

  • 21.1. Eastern Europe PEGylated Proteins Market Overview
  • 21.2. Eastern Europe PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia PEGylated Proteins Market

  • 22.1. Russia PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America PEGylated Proteins Market

  • 23.1. North America PEGylated Proteins Market Overview
  • 23.2. North America PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA PEGylated Proteins Market

  • 24.1. USA PEGylated Proteins Market Overview
  • 24.2. USA PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada PEGylated Proteins Market

  • 25.1. Canada PEGylated Proteins Market Overview
  • 25.2. Canada PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America PEGylated Proteins Market

  • 26.1. South America PEGylated Proteins Market Overview
  • 26.2. South America PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil PEGylated Proteins Market

  • 27.1. Brazil PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East PEGylated Proteins Market

  • 28.1. Middle East PEGylated Proteins Market Overview
  • 28.2. Middle East PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa PEGylated Proteins Market

  • 29.1. Africa PEGylated Proteins Market Overview
  • 29.2. Africa PEGylated Proteins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa PEGylated Proteins Market, Segmentation By Protein Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa PEGylated Proteins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. PEGylated Proteins Market Competitive Landscape And Company Profiles

  • 30.1. PEGylated Proteins Market Competitive Landscape
  • 30.2. PEGylated Proteins Market Company Profiles
    • 30.2.1. Merck & Co. Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Bristol Myers Squibb Company
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AstraZeneca PLC
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Roche Holding AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. PEGylated Proteins Market Other Major And Innovative Companies

  • 31.1. Gilead Sciences Inc.
  • 31.2. Novo Nordisk A/S
  • 31.3. Evonik Industries AG
  • 31.4. Viatris Inc.
  • 31.5. Regeneron Pharmaceuticals Inc.
  • 31.6. Biogen Inc.
  • 31.7. Vertex Pharmaceuticals Incorporated
  • 31.8. Lonza Group Ltd.
  • 31.9. Jazz Pharmaceuticals plc
  • 31.10. Ipsen Pharma
  • 31.11. Kyowa Kirin Co. Ltd.
  • 31.12. WuXi Biologics
  • 31.13. BioMarin Pharmaceutical Inc.
  • 31.14. Ligand Pharmaceuticals Incorporated
  • 31.15. Zydus Cadila

32. Global PEGylated Proteins Market Competitive Benchmarking

33. Global PEGylated Proteins Market Competitive Dashboard

34. Key Mergers And Acquisitions In The PEGylated Proteins Market

35. PEGylated Proteins Market Future Outlook and Potential Analysis

  • 35.1 PEGylated Proteins Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 PEGylated Proteins Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 PEGylated Proteins Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer